|
1
|
Okamura T, Tsujitani S, Korenaga D,
Haraguchi M, Baba H, Hiramoto Y and Sugimachi K: Lymphadenectomy
for cure in patients with early gastric cancer and lymph node
metastasis. Am J Surg. 155:476–480. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park YD, Chung YJ, Chung HY, et al:
Factors related to lymph node metastasis and the feasibility of
endoscopic mucosal resection for treating poorly differentiated
adenocarcinoma of the stomach. Endoscopy. 40:7–10. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Isozaki H, Tanaka N and Okajima K: General
and specific prognostic factors of early gastric carcinoma treated
with curative surgery. Hepatogastroenterology. 46:1800–1808.
1999.PubMed/NCBI
|
|
4
|
Maehara Y, Orita H, Okuyama T, Moriguchi
S, Tsujitani S, Korenaga D and Sugimachi K: Predictors of lymph
node metastasis in early gastric cancer. Br J Surg. 79:245–247.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Folli S, Dente M, Dell’Amore D, Gaudio M,
Nanni O, Saragoni L and Vio A: Early gastric cancer: prognostic
factors in 223 patients. Br J Surg. 82:952–956. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kitamura K, Yamaguchi T, Taniguchi H,
Hagiwara A, Sawai K and Takahashi T: Analysis of lymph node
metastasis in early gastric cancer: rationale of limited surgery. J
Surg Oncol. 64:42–47. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Habu H, Takeshita K, Sunagawa M and Endo
M: Lymph node metastasis in early gastric cancer. Int Surg.
71:244–247. 1986.PubMed/NCBI
|
|
8
|
Folli S, Morgagni P, Roviello F, et al;
Italian Research Group for Gastric Cancer (IRGGC). Risk factors for
lymph node metastases and their prognostic significance in early
gastric cancer (EGC) for the Italian Research Group for Gastric
Cancer (IRGGC). Jpn J Clin Oncol. 31:495–499. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kwee RM and Kwee TC: Predicting lymph node
status in early gastric cancer. Gastric Cancer. 11:134–148. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brennan MF: Current status of surgery for
gastric cancer: a review. Gastric Cancer. 8:64–70. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakajima T: Gastric cancer treatment
guidelines in Japan. Gastric Cancer. 5:1–5. 2002. View Article : Google Scholar
|
|
12
|
Krop IE: Chemokine signaling in gliomas:
prognostic factor, therapeutic target or both? Cancer Biol Ther.
5:1039–1041. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Burger JA and Kipps TJ: CXCR4: a key
receptor in the crosstalk between tumor cells and their
microenvironment. Blood. 107:1761–1767. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arya M, Patel HR and Williamson M:
Chemokines: key players in cancer. Curr Med Res Opin. 19:557–564.
2003. View Article : Google Scholar
|
|
15
|
Scotton CJ, Wilson JL, Scott K, et al:
Multiple actions of the chemokine CXCL12 on epithelial tumor cells
in human ovarian cancer. Cancer Res. 62:5930–5938. 2002.PubMed/NCBI
|
|
16
|
Koshiba T, Hosotani R, Miyamoto Y, et al:
Expression of stromal cell-derived factor 1 and CXCR4 ligand
receptor system in pancreatic cancer: a possible role for tumor
progression. Clin Cancer Res. 6:3530–3535. 2000.PubMed/NCBI
|
|
17
|
Ishigami S, Natsugoe S, Okumura H, et al:
Clinical implication of CXCL12 expression in gastric cancer. Ann
Surg Oncol. 14:3154–3158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Iwasa S, Yanagawa T, Fan J and Katoh R:
Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric
cancer is associated with lymph node and liver metastasis.
Anticancer Res. 29:4751–4758. 2009.PubMed/NCBI
|
|
19
|
Japanese Gastric Cancer Association.
Japanese classification of gastric carcinoma. 2nd English edition.
Gastric Cancer. 1. pp. 10–24. 1998, View Article : Google Scholar
|
|
20
|
Li C, Kim S, Lai JF, et al: Risk factors
for lymph node metastasis in undifferentiated early gastric cancer.
Ann Surg Oncol. 15:1464–1469. 2008.
|
|
21
|
Kanai T, Konno H, Maruyama K, et al: p53
overexpression and proliferative activity do not correlate with
lymph node metastasis in early gastric cancer. Eur Surg Res.
29:35–41. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kabashima A, Maehara Y, Kakeji Y, Baba H,
Koga T and Sugimachi K: Clinicopathological features and
overexpression of matrix metalloproteinases in intramucosal gastric
carcinoma with lymph node metastasis. Clin Cancer Res. 6:3581–3584.
2000.PubMed/NCBI
|
|
23
|
Yonemura Y, Ninomiya I, Ohoyama S, et al:
Correlation of c-erbB-2 protein expression and lymph node status in
early gastric cancer. Oncology. 49:363–367. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Salmaggi A, Gelati M, Pollo B, et al:
CXCL12 expression is predictive of a shorter time to tumor
progression in low-grade glioma: a single-institution study in 50
patients. J Neurooncol. 74:287–293. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Calatozzolo C, Maderna E, Pollo B, et al:
Prognostic value of CXCL12 expression in 40 low-grade
oligodendrogliomas and oligoastrocytomas. Cancer Biol Ther.
5:827–832. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sasaki K, Natsugoe S, Ishigami S, et al:
Expression of CXCL12 and its receptor CXCR4 correlates with lymph
node metastasis in submucosal esophageal cancer. J Surg Oncol.
97:397–402. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sasaki K, Natsugoe S, Ishigami S, et al:
Expression of CXCL12 and its receptor CXCR4 in esophageal squamous
cell carcinoma. Oncol Rep. 21:65–71. 2009.PubMed/NCBI
|
|
28
|
Wagner PL, Hyjek E, Vazquez MF, et al:
CXCL12 and CXCR4 in adenocarcinoma of the lung: association with
metastasis and survival. J Thorac Cardiovasc Surg. 137:615–621.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoshitake N, Fukui H, Yamagishi H, et al:
Expression of SDF-1 α and nuclear CXCR4 predicts lymph node
metastasis in colorectal cancer. Br J Cancer. 98:1682–1689.
2008.
|
|
30
|
Barbieri F, Bajetto A, Stumm R, et al:
Overexpression of stromal cell-derived factor 1 and its receptor
CXCR4 induces autocrine/paracrine cell proliferation in human
pituitary adenomas. Clin Cancer Res. 14:5022–5032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rempel SA, Dudas S, Ge S and Gutiérrez JA:
Identification and localization of the cytokine SDF1 and its
receptor, CXC chemokine receptor 4, to regions of necrosis and
angiogenesis in human glioblastoma. Clin Cancer Res. 6:102–111.
2000.PubMed/NCBI
|
|
32
|
Bajetto A, Barbieri F, Dorcaratto A, et
al: Expression of CXC chemokine receptors 1–5 and their ligands in
human glioma tissues: role of CXCR4 and SDF1 in glioma cell
proliferation and migration. Neurochem Int. 49:423–432. 2006.
|
|
33
|
Barbero S, Bonavia R, Bajetto A, et al:
Stromal cell-derived factor 1α stimulates human glioblastoma cell
growth through the activation of both extracellular
signal-regulated kinases 1/2 and Akt. Cancer Res. 63:1969–1974.
2003.
|
|
34
|
Li M and Ransohoff RM: The roles of
chemokine CXCL12 in embryonic and brain tumor angiogenesis. Semin
Cancer Biol. 19:111–115. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guleng B, Tateishi K, Ohta M, et al:
Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates
in vivo tumor growth by inhibiting angiogenesis in a
vascular endothelial growth factor-independent manner. Cancer Res.
65:5864–5871. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Orimo A, Gupta PB, Sgroi DC, et al:
Stromal fibroblasts present in invasive human breast carcinomas
promote tumor growth and angiogenesis through elevated SDF-1/CXCL12
secretion. Cell. 121:335–348. 2005. View Article : Google Scholar : PubMed/NCBI
|
